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Hematopoietic stem cells undergo regulated proliferation and differentiation 
in  a  series  of tissue  environments,  chiefly, the  liver  prenatally  and  the  bone 
marrow postnatally. The relationships between the stem cell and each of these 
environments appear to be specific and critical but are poorly understood. We 
have described  (1) a  means of characterizing the biological potential of mouse 
hematopoietic stem cells during development through this series of environments 
in  vivo by introducing the cells via the placental  circulation into early fetuses 
near the inception of liver hematopoiesis. The use of W-locus mutant recipients, 
with  a  macrocytic  anemia  and  reduced  stem  cell  proliferation  (2),  confers  a 
selective advantage on normal donor cells without irradiation of the recipient. 
The host's immunological immaturity (3) circumvents rejection problems. 
Fully allogeneic cells taken from livers of fetuses close in age to the recipients 
are able to seed the host's liver and progress to the bone marrow. In the best 
cases, the donor stem cells undergo lifelong self-renewal and coordinate differ- 
entiation into myeloid as well as lymphoid lineages. Thus, fetal liver contains a 
population  defined  as  developmentally  totipotent  hematopoietic  stem  cells 
(THSC)' (4). 
The present study was undertaken to learn whether cells that are the counter- 
part of fetal liver THSC are still present in adult bone marrow. The results of 
transplacental  inoculation  of genetically  marked  marrow  cells  into  early  W- 
mutant fetuses show that, despite maturation in the bone marrow, THSC capable 
of seeding the fetal liver and undergoing sustained self-renewal and differentia- 
tion into myeloid and lymphoid cells are  indeed present.  However,  their self- 
renewal capacity is reduced and, along with other irreversible changes, histocom- 
patibility restriction has become a  partially limiting factor, especially at the H-2 
locus. 
Materials and Methods 
Mice.  The recipient fetuses in all transplacental injections were from matings involving 
W-locus mutant alleles.  The macrocytic anemia of these genotypes is most severe (and 
This work was supported by grants HD-01646, CA-06927, and RR-05539 from the U. S. Public 
Health Service, and by an appropriation from the Commonwealth  of Pennsylvania. Address corre- 
spondence to B. M. at the Institute for Cancer Research. The present address of R. A. F. is the 
Department of Internal Medicine, University of Texas Health Science Center at Dallas, Dallas, TX 
75235. 
l Abbreviations used in this paper:  THSC, totipotent hematopoietic stem cells. 
J. ExP. MED. © The Rockefeller University  Press - 0022-1007/84/03/0731/15 $1.00 
Volume 159  March  1984  731-745  731 732  ADULT  HEMATOPOIETIC  STEM  CELL  DEVELOPMENT  IN  FETUSES 
lethal shortly after birth) in W/W and is progressively less so, and compatible with viability, 
in W/W  ~, W"/W  ~, W/W  j, WI/W  f, and WV/+. 141/+ is nonanemic (5, 6). In all segregating 
matings, coat color differences also due to W alleles enabled the genotypes to be recog- 
nized. Wf/W  l mice, unlike W/W and W~/W v, are fertile. Injected W/W  ~  fetuses were from 
matings between W/+ and WV/+ heterozygotes congenic with the C57BL/6 strain.  In a 
few experiments, W/+-C57BL/6 animals used in matings had the Hbb  d  (diffuse) hemoglobin 
electrophoretic variant substituted for the Hbb  s (single) allele characteristic of the congenic 
C57BL/6 strain, wf/w  f homozygotes were coisogenic with the C3H/He inbred strain as 
a result of a mutation in that strain and were originally obtained from the Institut Pasteur, 
Paris, France (6). Injected W/W  f fetuses were from matings of Wf/WLC3H homozygotes 
with W/+ heterozygotes of either the C57BL/6 or WH strains.  W/W fetuses used for 
histological examination were from matings between W/+-C57BL/6 females and 141/+- 
WH males. 
Adult mice used as bone marrow donors were all of nonanemic genotypes and were 
from Icr sublines of inbred strains  C3H,  DBA/2,  C57BL]6, and C3H.SW (H-2~/H-2  b, 
congenic with C3H), or their F~ hybrids. Some H-2~/H-2  k mice congenic with C57BL/6 
were also used; these were derived from animals kindly sent by Edward A. Boyse of the 
Sloan-Kettering Institute, New York. 
Microinjection of Cells from Adult Bone Marrow.  The microinjection procedure was the 
same as originally described by Fleischman and Mintz (1).  Instead of fetal liver donor 
cells, suspensions of bone marrow cells from mice 2-4 mo old were prepared, and 5 × 
105 cells  were  injected into  the  placental circulation of fetal recipients on  day  11  of 
gestation, as described by Blanchet et al. (7). 
Blood Analyses.  Blood was collected from the incised tail tip or the retroorbital sinus, 
and  erythrocyte lysates  were  analyzed  for  the  relative  proportions  of strain-specific 
hemoglobin variants due to alleles at the Hbb locus (8).  The transparentized gels were 
densitometrically scanned as previously described (4). Strain-specific variants of immuno- 
globulin allotypes, indicative of the  B  lymphocyte strains of origin,  were analyzed by 
Ouchterlony double-diffusion immunoprecipitation in agar,  using allotype-specific anti- 
sera. 
Histology.  Liver tissue was fixed and stained as previously described (4). 
Results 
Development of Adult Cells in Fetal Livers 
At ~ 11  d  of gestation,  the  liver of a  normal  mouse fetus begins to increase 
rapidly  in  size  and  to  acquire  a  uniform  dark  red  color  due  to  the  onset  of 
hematopoiesis and  hemoglobin  production  (9).  By comparison,  livers of W/W 
fetuses, characterized by a  severe hypoplastic anemia and a defect in the hema- 
topoietic stem cells (2), are reduced in size and pale in color throughout fetal life 
(10). 
To  learn  whether  normal  adult  bone  marrow,  like  normal  fetal  liver  (4), 
contains  hematopoietic  stem  cells  able  to  competitively  seed  the  fetal  liver 
microenvironment, four W/W experimental fetuses, identified by their relative 
pallor and  residual  anemia,  were autopsied on day  18 of gestation,  1 wk after 
the injection of bone marrow cells via the placenta. Two proved to be hemato- 
poietic mosaics, as seen by the presence of 25 and 40% donor-type hemoglobin, 
respectively, in  the peripheral blood (data not shown).  The two unsuccessfully 
treated  nonmosaics,  which  were  seen  in  sections to  be  uniformly hypocellular 
(Fig.  1 A and C), were indistinguishable from untreated W/W fetuses and, along 
with the latter, served as controls. The livers of both mosaic animals had several 
discrete, nonraised, dark red areas easily visible on the background of otherwise 
pale liver tissue (Fig.  1 B). Such regions were distinct individual clusters of rapidly FLEISCHMAN  AND  MINTZ  733 
FIGURE  1.  Histological sections of fetal livers at  18 d of gestation.  (A) W/W-(C57BL/6  x 
WH) mutant anemic control. (B) W/W-(C57BL/6  x WH) mutant fetus with 40% donor-strain 
hemoglobin  in the peripheral blood, after receiving normal (+/+-C57BL/6) adult bone marrow 
cells on day 11 of gestation. (C) Higher magnification of (A) showing the uniform hypocellu- 
larity and the rarity of hematopoietic cells. (D) Higher magnification of (B) showing the focal 
region of hypercellularity  evident in (B), with numerous hematopoietic  cells. Stained  with 
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proliferating hematopoietic cells clearly derived from the donor source (Fig. 
1 D). Each of these hyperceilular foci contained predominantly erythroid cells, 
with smaller numbers of identifiable granulocytic and megakaryocytic cells. 
Survival to Birth 
The  largest  experimental  group  consisted  of  fetuses  from  W/+  x  WV/+ 
matings, in which the W/W  v segregants, with a relatively severe genetic defect, 
offer the greatest possibility of competitive engraftment by normal donor stem 
cells (4).  All  were on  the C57BL/6  (H-2b/H-2 b) strain  background.  To  learn 
whether histocompatibility and strain differences affected the outcome, we used 
donor bone marrow cells from a variety of inbred strains (Table I). Three groups 
of donors shared at least a haplotype at the H-2 locus with the recipients; these 
were C57BL/6, (C3H ×  C57BL/6)FI, and C3H.SW (H-2b/H-2b). In three other 
groups, the donors were H-2-incompatible with the recipients; these were con- 
genie H-2h/H-2k-C57BL/6,  DBA/2 (H-U/H-U), and C3H (H-2k/H-2k). 
Of a  total  of 1,458  injected fetuses in  these groups,  there were  1,064  live 
births, or an overall survival rate of 73%. Losses of entire litters accounted for a 
major proportion of the missing animals. Incompatibility for H-2 alleles clearly 
did not affect survival to birth  (Table I). There was slightly superior survival 
with C57BL/6 donors, whether H-2-compatible or -incompatible. 
TABLE  I 
Survival of W/WV-C57BL/6 Fetuses to Birth after Injection with 
H-2-Compatible vs.  -Incompatible Cells from Adult Bone Marrow of 
Various Strains 
W/W  v neonates 
Number  Number  Percent 
Donor genotype  injected  born (%)  Number  of ex- 
pected* 
H-2 compatible 
C57BL/6'  151  129 (85)  17  46 
(C3H x  C57BL/6)F~  86  57 (66)  11  73 
C3H.SW  284  191 (67)  19  33 
Totals  521  377 (72)  47  43 
H-2 incompatible 
H-2k/H-2*-C57BL/6 *  230  187 (81)  23  42 
DBA/2  262  185 (71)  32  63 
C3H  445  315 (71)  34  36 
Totals  937  687 (73)  89  42 
* In matings of W/+ x  W~/+, each segregating genotype would be expected to 
constitute 25% of the animals born, assuming equal survival in utero. Because 
the number of W/W  ~ neonates actually seen was significantly below 25%, for 
purposes of this calculation the number of W/W  ~ births expected theoretically 
was derived by dividing the total of all other segregants (+/+, W/+, and W~/ 
+) born by three, thus representing an equal (25%) share of all births. 
* In these experiments, the C57BL/6 donors and the W/W  ~ recipients from H- 
d  d  d/  s  k  k  s  s  2/H-2 -C57BL/6  (Hbb /Hbb ) donors were Hbb /Hbb  or Hbb /Hbb , thereby 
permitting donor erythroid cells to be distinguished from those of the hosts by 
means of their hemoglobin differences; all other donors were Hbbd/Hbb  d or 
Hbba/Hbb  s and all other recipients were Hbb*/Hbb  ~. FLEISCHMAN  AND  MINTZ  735 
More  than  half of the expected  W/W  v segregants  appeared  to have  died  in 
utero,  or else  were  destroyed  by  mothers  soon  after  birth.  The  known  poor 
viability of W/W  ~ on the C57BL/6  strain background (11), in contrast to an F~ 
hybrid background, undoubtedly accounts for the low survival of W/W  ~. Nearly 
identical rates of survival were observed in comparisons between congenic donors 
with H-2 differences but  in  which  one member  had the same H-2 type as  the 
recipient,  i.e.,  C57BL/6  and H-2k/H-2k-C57BL/6  or C3H.SW  and C3H (Table 
I).  Thus,  graft-vs.-host  disease  directed  against  H-2  antigens  of  the  host  is 
apparently ruled out as a cause of prenatal losses in allogeneic combinations. 
Self-renewal of Donor Stem Cells in Severely Defective Recipients 
In  the  first week  after birth,  71  W/W~-C57BL/6  recipients  among  the  136 
animals  born  were  identified,  by  means  of  the  hemoglobin  electrophoretic 
marker  in  peripheral  blood,  as  having  erythrocytes  of the  donor  strain.  The 
calculated  frequency with which each of the donor genotypes  contributed any 
cells was strikingly similar (approximately half for each genotype) (Table II). Of 
the 71  mosaic W/W  ~ neonates,  19 did not survive to weaning and are therefore 
designated in the table as "unclassified"  with respect to the kinetics of postnatal 
replacement of host by donor cells.  The  52 survivors were analyzed at regular 
intervals  with  the  hemoglobin  marker  previously  found  to  reflect  not  only 
erythrocyte replacement but also, over time, the relative success of engraftment 
by self-renewing stem cells (4). As in our observations when the donor cells were 
TABLE  II 
Frequency of Successful  Injection of Bone Marrow Cells and of Stem Cell Engraftment*  in 
Relation to Histocompatibility  and Strain Differences Between Donors and C57BL/6 Hosts 
Donor genotype 
Percent 
W/W  ~ neo-  Number  Number 
nates posi-  unclassi-  with tran- 
tive for  fled  sient re- 
donor  placement 
cells* 
Stem cell engraftment 
Percent  Number 
Success 
14-2 compatible 
C57BL/6  a  59  2  2  6  60 
(C3H x  C57BL/6)F]  45  0  1  4  80 
C3H.SW  58  4  1  6  55 
Totals  54  6  4  16  62 
H-2 incompatible 
H-2k/H-2k-C57BL/6 |  52  2  4  6  50 
DBA/2  41  4  6  3  23 
C3H  59  7  11  2  10 
Totals  51  13  21  11  27 
* Successful engraftment was ascertained  from the persistence of donor strain hemoglobin variants 
in repeated postnatal analyses. 
* Calculated  by  dividing  the  number  of W[W  ~ animals positive  for  donor  cells  (the  sum  of the 
unclassified, transient, and engraftment groups in this table) by the actual total number (including 
negatives) of W]W  v animals born and tested for presence of the donor-specific hemoglobin variant 
(Table l, third column of numbers). Animals that did not survive to weaning, and therefore yielded 
insufficient data on postnatal replacement by donor cells, are designated as unclassified. 
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from  fetal  livers,  there  were  two  biological  classes  of results:  Some  animals 
showed only a  brief proliferation of donor strain  erythroid cells,  of <12  wk 
duration;  these  were described as  having  "transient  replacement".  In  others, 
proliferation was sustained for a  much longer period;  these were classified as 
having either "complete replacement," or as "limited replacement" if donor strain 
cells  were  substantially  represented but  limited in  duration  or  extent.  True 
engraftment by stem cells has been shown (4)  to be attributable only to those 
cases in  the "complete" or "limited" group.  The frequency of these outcomes 
differed in  relation to some histocompatibility and strain  differences between 
bone marrow donors and hosts, as will now be presented in detail. 
Syngeneic and semisyngeneic combinations.  With syngeneic (C57BL/6-Hbbd/Hbb d 
or-Hbbd/Hbb  ~) or Fl semisyngeneic donors (C3H x  C57BL/6),  10 of the 15 W/ 
reW-C57BL/6  recipients (67%  combined) that  were initially positive for donor 
strain  erythroid cells  achieved  and  maintained  complete replacement in  the 
erythroid lineage (Table  II;  Fig.  2A  and  B)  and  were therefore successfully 
engrafted with  ongoing stem  cells.  Hematocrit  measurements confirmed the 
associated correction of the recipients' genetic anemia (data not shown). Similar 
results were obtained in two recipients with sustained replacement by semisyn- 
geneic bone marrow ceils from (C57BL/6 ×  DBA/2)Fl hybrid donors (data not 
shown). 
Nearly half of these cases died of unknown causes between 8 and  12 mo of 
age, despite histocompatibility. This surprising result cannot be attributed to loss 
of tolerance or to graft-vs.-host disease, especially in the purely syngeneic cases 
(Fig. 2A). Recurrent anemia was seen in one case (Fig.  2A, open circles) after 
the dramatic decline and disappearance of donor-derived erythrocytes and may 
have contributed to the deaths of other animals in which accurate hematologic 
data could not be obtained postmortem. 
Allogeneic H-2-compatible combinations.  With H-2-compatible but otherwise al- 
logeneic C3H.SW donors, a  high frequency (55%) of stem cell engraftment in 
W/W~-C57BL/6 hosts was also obtained (Table II, Fig. 2 C). Except for one early 
death at 10 wk of age, those hosts achieving complete replacement have thus far 
survived for >1 yr. One case of limited replacement was also observed to have a 
recurrence of mild anemia before death at 50 wk of age (Fig. 2 C, open inverted 
triangles). Additional cases of successful stem cell engraftment were found at a 
high frequency in F1 W/W v and W/W (WH × C57BL/6) hybrid recipients (H-U~ 
H-2 b) after injection of bone marrow cells from allogeneic but H-2-haplotype- 
compatible DBA/2 donors (H-2a/H-2 a) (data not shown). 
Congenic H-2-incompatible combinations.  With H-2k/H-2k-C5 7BL/6 donors in W/ 
W~-C57BL/6 (H-2b/H-2 b) recipients with at least one Hbb  a allele substituted for 
Hbb  ~ at the hemoglobin marker locus, the results for the first  12 wk appeared 
similar to those in the H-2-compatible combinations (Table II, Fig. 3A): 5 of the 
11 animals were characterized by complete replacement and one additional case 
was tentatively considered to represent stem cell engraftment although it died 
shortly after weaning (see Fig. 5, open inverted triangles). Between 3 and 5 mo 
of age, however, all five of the remaining animals died abruptly. All had appeared 
healthy just  before their deaths and did  not exhibit the runting,  weight loss, 
hunched posture, or skin lesions seen in mice with graft-vs.-host disease.  None t00 - 
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FIGURE 2.  In vivo postnatal kinetics of erythroid replacement in severely anemic W/W ~- 
C57BL/6 hosts by H-2-compatible donor cells from adult bone marrow. (A) Syngeneic donors 
(C57BL/6) with Hbb  a substituted for one or both alleles at the hemoglobin marker locus. (B) 
Semisyngeneic F1 donors (C3H x  C57BL/6) into hosts of the C57BL/6 parental (P) strain. 
(C)  Allogeneic, H-2-compatible donors (C3H.SW).  Erythroid replacement was  determined 
from electrophoresis of strain-type hemoglobin variants in erythrocyte ]ysates at progressive 
host ages.  Numbers shown are those hematocrit measurements that fell below the normal 
range for nonanemic mice of these strains. The  ~" (dagger)  indicates the age at death of 
experimental animals. 
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FIGURE 3.  In  vivo postnatal kinetics of erythroid replacement in severely anemic W/W  ~- 
C57BL/6 hosts by H-2-incompatible donor cells from adult bone marrow. (A) Congenic donors 
(H-2~/H-2*-C57BL/6).  (B)  Allogeneic donors  (DBA/2).  (C)  Allogeneic donors  (C3H).  The 
hosts used in A had an Hbb  'l substitution at the diagnostic hemoglobin locus. Note the expanded 
time scale in (C). Numbers indicate abnormally low hematocrit readings. 
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were anemic.  Postmortem changes prevented meaningful  histological examina- 
tion of the tissues in these cases. 
Allogeneic H-2-incompatible combinations.  With DBA/2 (Fig. 3B) or C3H (Fig. 
3 C) donors, engraftment of stem cells proved to be more difficult to achieve in 
W/W°-C57BL/6 hosts. Nevertheless, at least one example of complete or limited 
replacement  was obtained in  each group.  By far the  most frequent result  was 
either transient  replacement for only 8-12 wk, or death of the recipient before 
weaning (unclassified). The very low initial levels of donor strain erythrocytes in 
many of these unclassified cases strongly suggests that stem cell engraftment was 
unlikely to have occurred, even if the animals had survived for a longer period. 
A comparison of the congenic donor strains C3H.SW (Fig. 2C) and C3H (Fig. 
3 C) is particularly instructive.  In both cases, the W/W~-C57BL/6 recipients had 
nearly  identical  rates  of survival in  utero  (Table  I),  incidence  of donor  strain 
erythroid cells neonatally, and survival to weaning (Table II). Yet the frequency 
of stem cell engraftment was dramatically different, in favor of the H-2-compat- 
ible C3H.SW donors. However, the H-2*/H-2* constitution of C3H cannot alone 
explain this discrepancy, in view of the high frequency of stem cell engraftment 
from H-2k/H-2*-C57BL/6 donors in C57BL/6 recipients (Table II, Fig. 3 A). 
Comparison  of Erythrocyte and B Lymphocyte Replacement 
Serum samples from 15 W/W~-C57BL/6 experimental mice were analyzed for 
donor-specific immunoglobulin  allotype as a  marker  of B  lymphocytes (Table 
III). The five cases with only transient  erythroid substitution in the first  12 wk 
of life had no detectable donor strain  immunoglobulin.  Although four of these 
were tested a few wk after loss of donor-derived erythrocytes, the lymphoid cells, 
with  a  relatively  longer  half-life  (12),  would  be  expected  to  disappear  more 
slowly. In contrast to the transient cases, all 10 with limited or complete erythroid 
replacement were positive for donor strain allotype. 
In its limited erythroid replacement, for approximately  14 wk, the animal  in 
Fig. 3 C (open circles) was only marginally superior to transient cases such as the 
one (closed triangles)  in the same figure.  Nevertheless, the classification appar- 
ently represents a  valid distinction signifying THSC engraftment in the former 
TABLE  III 
Presence of Donor Strain Immunoglobulin  Allotype in Relation to the Kinetics 
of  Erythroid Replacement 
Donor genotype*  Age (months) 
Kinetics of erythroid re- 
placement 
Transient*  Limited or 
complete* 
(C3H × C57BL/6)F~  9-10  0/1  4/4 
C3H.SW  6  4/4 
C3H  3  0/4  2/2 
Totals  0/5  10/10 
* Donor strain allotype was distinguishable in all cases from the allotype of the 
W/Wv-C57BL/6  recipients by Ouchterlony double-diffusion  tests. 
* Expressed as the number of animals positive for immunoglobulin of the donor 
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and not in the latter. This is seen from the presence of donor strain allotype at 
3  mo of age  in  the  former; at  6  and  9  mo,  there is a  progressive decline and 
extinction of donor allotype (Fig.  4A and B).  On the other hand, the serum of 
an animal characterized by sustained complete replacement with donor-derived 
erythroid cells (Fig.  3 C, closed circles) was positive for immunoglobulin  of the 
donor allotype at all ages tested up to 9  mo (Fig. 4 C). 
Self-Renewal  of Donor Stem Cells in Mildly Defective Recipients 
Unlike  all  the  cases  involving severely defective W/W  v recipients,  discussed 
above, transplacental inoculation of normal adult bone marrow cells into fetuses 
of the  mildly defective wf/w  f  genotype yielded no  examples of successful  en- 
graftment  in  a  series  of  183  injected.  The  recipients  (all  of the  C3H  strain) 
received marrow cells from H-2-compatible (C57BL/6 ×  C3H)F1 or H-2-incom- 
patible  (C57BL/6)  donors.  These  results  contrast  sharply  with  those  of our 
earlier  study  (4)  in  which  fetal  liver  cell  inoculations  into  111  WY/W  f  fetuses 
yielded 6% with stem cell engraftment and at least 4% with transient donor-type 
erythroid cells. 
Fetuses of a  slightly more defective genotype, W/W  f  from matings of (141/+- 
C57BL/6  ×  wf/wf-c3H),  proved  to  be  more  favorable hosts  than  WY/W  f  for 
competitive seeding by bone marrow cells from normal adult donors.  Injection 
of 70 fetuses with cells from H-2-compatible H-2k/H-2k-C57BL/6 donors resulted 
in  57  live births of which 25  were W/W  f and  11  of these were initially positive 
for donor lineage erythrocytes (Fig. 5). Although four of the cases proved to be 
transient, six have thus far shown continued proliferation of donor stem cells for 
>9 mo. In an additional case (Fig. 5, closed squares), limited donor cell renewal 
occurred for several months.  Further  instances  of stem  cell engraftment  were 
obtained with marrow from the H-2-compatible C3H or C57BL/6 strains (three 
cases, along with  four transient ones) (data not shown).  Sustained  engraftment 
was also  observed with  an  allogeneic H-2-incompatible  combination  (one case) 
with C57BL/6 donor cells and a  W/W  f (H-2a/H-2  k) recipient derived from (W/ 
+-WH ×  wf/wf-c3H) (data not shown). 
Discussion 
The present results,  in relation to our previous tests of fetal liver grafts into 
early  fetuses  (4),  demonstrate  that  adult  bone  marrow,  although  many  cell 
FIGURE 4.  Serial tests for donor allotype immunoglobulin in  two  mice with prenatally 
engrafted bone marrow stem cells. Immunoprecipitation by antiserum (center wells) against 
the donor strain allotype (controls in upper right wells) shows in A the decreasing presence of 
the donor type in serum of a case of limited erythroid replacement (Fig. 3C, open circles) 
from 3 mo (upper left well) to 6 mo (lower right well) of age, and its loss in B from 6 mo 
(lower right) to 9 mo (leftmost well). In C,  the  serum of a case with complete erythroid 
replacement (Fig. 3 C, closed circles) shows continued presence of donor allotype at  3 mo 
(lower right well), 6 mo (leftmost well) and 9 mo (upper left well) of age. FLEISCHMAN  AND  MINTZ  741 
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FIGURE 5.  In vivo postnatal kinetics of erythroid replacement in mildly  anemic W/W  f hosts. 
Donors of the parental (P) H-2k/It-2k-C57BL/6 strain were H-2 compatible with the (C57BL/ 
6 x C3H)F~ background of the hosts. 
generations  removed from  the  precursor  cells in  the  fetal  liver,  contains  cells 
that are still  able to proliferate and develop in the fetal liver environment  (Fig. 
1) and subsequently to colonize the bone marrow. The cells have also conserved 
the  essential  properties  of totipotent  hematopoietic  cells,  i.e.,  the capacity for 
long-term  self-renewal  and  for  coordinate  differentiation  into  myeloid  and 
lymphoid  lineages  (Figs.  2-4,  Table  III),  similar  to  the  THSC  taken  directly 
from fetal liver. 
However, significant  and  irreversible  maturational  changes  have apparently 
occurred  during  ontogeny,  specifically among  those bone marrow  THSC  still 
able to seed the fetal liver. One change is a decreased potential for self-renewal. 
This  is  evident from a  comparison  of the  results  with  bone marrow  and  fetal 
liver  inoculations  into  severely defective (W/W v)  vs.  mildly defective (Wf/W  f) 
fetuses. With bone marrow, successful stem cell engraftment occurred at a high 
frequency in W/W ~ (Table II) but failed to occur in W//W  f  whereas fetal liver 
stem cells yielded successful engraftment  in  these and  all  defective genotypes 
tested, albeit at a  lower frequency in the less defective ones, such as Wf/W  /  (4). 
Thus, bone marrow cells in the fetal environment were less successful in sustain- 
ing themselves than were fetal liver cells when the advantage to the donor cells 
was marginal.  The more limited lifespan of some animals with complete replace- 
ment of their  hematopoietic cells by bone marrow donor cells, even in purely 
syngeneic  or  in  semisyngeneic  combinations  (Fig.  2A  and  B),  could  also  be 
accounted for by exhaustion of donor stem cells after extensive proliferation in 
vivo,  especially since  seeding  is  likely to  have  occurred  by only one  or a  few 
donor cells (4, and unpublished data).  A  decline in self-renewal of adult hema- 
topoietic stem cells is likewise indicated by other kinds of experiments (13, 9). 
From the standpoint of self-renewal potential,  fetal liver grafts might therefore 
be expected to be superior to bone marrow grafts in human clinical cases. 
There  is  evidence  that  changes  in  expression  of other  genes,  specifically 742  ADULT  HEMATOPOIETIC  STEM  CELL  DEVELOPMENT  IN  FETUSES 
involved in  differentiation, may become manifest during the stem cell phase, 
rather than in a single step from stem cell to differentiated progeny cell. Thus 
different kinds of stem cells would be generated that nevertheless share the basic 
features of THSC.  As an example, we have previously noted (7)  that the stem 
cells of adult bone marrow, after transplacental inoculation into W/W  v fetuses, 
generate erythrocytes  which lack a fetal stage-specific erythrocyte  antigen. There- 
fore,  adult  marrow  THSC  have  an  adult  differentiation  program  that  they 
continue to express even when maturation occurs in a fetal environment. In the 
present data, the few cases of stem cell engraftment by fully allogeneic DBA/2 
or C3H  bone  marrow donors in  W/W~-C57BL/6  recipients (Table  II,  Fig.  3) 
may also partly signify seeding by a rare class of "adult" THSC of relatively less 
mature status with respect to its histocompatibility gene expression. 
Histocompatibility relations between cells of adult donors and fetal hosts were 
explored in various combinations and yielded some surprising results. Successful 
engraftment occurred (in severely defective W/Wv-C57BL/6 recipients) at a high 
frequency with syngeneic and semisyngeneic combinations (Table  II).  Yet,  as 
already noted, nearly half of these cases died at 8-12 mo. The importance of H- 
2  matching was seen in  the equally frequent success of engraftment with H-2 
compatible  but  otherwise allogeneic (C3H.SW)  marrow cells.  The  somewhat 
better survival among these animals,  in  comparison with syngeneic C57BL/6 
donors, is without obvious explanation. H-2 incompatibility in otherwise synge- 
neic C57BL/6  donors led to high initial representation of donor-derived cells 
but was followed by relatively early deaths, at 3-5 mo. Fully allogeneic (DBA/2 
or C3H) donors gave the poorest success, as expected, but included at least one 
successful case of engraftment in each group. 
While the superiority of C3H.SW  over C3H  in achieving engraftment may 
seem expected in view of the H-2 match between C3H.SW  and the C57BL/6 
recipient, it should be noted that H-2k/H-2k-C57BL/6  donors were mismatched 
with their recipients but gave a high initial frequency of stem cell engraftment. 
The fact that the H-2  k region of H-2k/H-2k-C57BL/6 was derived from the AKR 
strain rather than from C3H (14) may account for the difference between the 
effect of 1-1-2  k in these C57BL/6  congenic donors and in C3H donors, if a gene 
closely linked to H-2 plays a significant role in hematopoietic stem cell regulation. 
Some 1"-1-2  k inbred strains, including C3H but not AKR, have indeed been found 
to yield relatively more limited proliferation of bone marrow cultures (15,  16). 
The immunological relations between adult donors and fetal hosts have no 
counterpart at other ages although H-2 compatibility in adult hematopoietic cells 
may be essential in many ways (17,  18),  e.g., in stem cell regulation by stromal 
cells.  Our hosts are not yet capable of resistance to or rejection of donor cells (3, 
19).  The donor cells are at first represented in marginal numbers, unlike the 
usual  case  with  large  numbers  of bone  marrow  cells  introduced  into  adult 
recipients that retain significant immunocompetence despite irradiation (20-22). 
Immunocompetent T  lymphocytes capable of graft-vs.-host reactivity would be 
present in only small numbers in the bone marrow inoculum initially introduced 
into fetal recipients and an inoculum > 10 times greater is required in adult mice 
to induce graft-vs.-host disease, which then occurs with delayed onset (23). 
The deaths at 3-5 mo of successfully engrafted recipients of H-2a/H-2k-C57BL/ FLEISCHMAN  AND  MINTZ  743 
6 bone marrow may have resulted from gradual replacement of the host's own 
lymphocytes with lymphocytes of the donor strain, at a slower rate than erythroid 
cell replacement (e.g., Fig. 4). The ultimate complete or nearly complete presence 
of H-2-incompatible lymphocytes might produce an acquired immunodeficiency 
syndrome due to 1-1-2 restriction of lymphocyte function in a histoincompatible 
host (24) and result in sudden deaths from infection. If this is the case, the long- 
term survival of some cases with purely allogeneic donor cells might have involved 
less extensive lymphocyte replacement, but no data are available. 
The proliferative potential of the THSC  greatly exceeds that estimated for 
the committed erythroid stem cell, not only in our animals with the longest and 
most complete replacement but even with engraftment of a stem cell with limited 
self-renewal (25, 26). In all instances sufficiently examined for both myeloid and 
lymphoid derivatives in our transplants of bone marrow (15 cases) or of fetal 
liver  (10  cases),  both  lineages have appeared  in  a  coordinated fashion  when 
engraftment was sustained. In addition, extinction of the erythroid lineage was 
accompanied by extinction of the lymphoid lineage in one case (Fig.  3 C, open 
circles; Fig. 4A and B), at a rate consistent with the longer half-life of lymphoid 
cells (12). Therefore, the replacement in fetal recipients at the outset of hema- 
topoiesis is attributable  to a  shared precursor,  the THSC,  and does not lend 
support to the hypothesis (27) of separate stem cells for the two lineages. 
Other questions concerning the hierarchy of increasingly committed stem cells 
in hematopoiesis may be clarified by experimental entry into the hematopoietic 
system at the early fetal stage. These include control of progression through the 
developmental hierarchy, and the roles of mutant genes and tumorigenic viruses, 
in the stem cells or their tissue environments, in the stage-specific ontogeny of 
malignancies and other hematopoietic diseases. 
Summary 
Bone marrow of normal adult mice was found, after transplacental inoculation, 
to contain cells still able to seed the livers of early fetuses. The recipients' own 
hematopoietic stem cells, with a W-mutant defect, were at a selective disadvan- 
tage.  Progression  of donor  strain  cells  to  the  bone  marrow,  long-term  self- 
renewal, and differentiation into myeloid and lymphoid derivatives was consistent 
with the engraftment of totipotent hematopoietic stem cells (THSC) comparable 
to precursors previously identified (4) in normal fetal liver. More limited stem 
cells, specific for the myeloid or lymphoid cell lineages, were not detected in 
adult bone marrow. The bone marrow THSC, however, had a generally lower 
capacity for self-renewal than did fetal liver THSC.  They had also embarked 
upon irreversible changes in gene expression, including partial histocompatibility 
restriction. While completely allogeneic fetal liver THSC were readily accepted 
by fetuses, H-2 incompatibility only occasionally resulted in engraftment of adult 
bone marrow cells and, in these cases, was often associated with sudden death at 
3-5  mo.  On  the other hand,  H-2  compatibility,  even with  histocompatibility 
differences at other loci, was sufficient to ensure long-term success as often as 
with fetal liver THSC. 
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